Mintz Levin Attorney Jeffrey M. Wiesen Named Best Lawyers’ Boston Biotechnology Law “Lawyer of the Year”

09.20.2012 - Boston, MA

Jeffrey M. Wiesen, a Member of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and Chair of the firm’s Life Sciences Practice, has been named the Best Lawyers’ 2013 Boston Biotechnology Law “Lawyer of the Year.”

Best Lawyers, which compiles annual listings of outstanding lawyers through a rigorous peer-review process, selects a single lawyer in each specialty in each community to honor as the “Lawyer of the Year.” These lawyers have received particularly high ratings by earning a high level of respect among their peers for their abilities, professionalism, and integrity.

Mr. Wiesen has been an active participant and leader in the biotechnology industry since its inception in the late 1970s. He was involved in the formation of some of the earliest companies, and the structuring and negotiation of some of the industry’s earliest strategic alliances, venture financings, and public offerings. His clients range in size from newly formed start-up ventures to substantial public companies. Mr. Wiesen assists these companies with a range of transactions, both domestic and international, including private and public finance, mergers and acquisitions, strategic alliances and joint ventures, and technology transfer and cross-transfer agreements, as well as providing general legal advice, and he has successfully structured, coordinated, and negotiated technology-based transactions with numerous worldwide pharmaceutical and chemical companies.

Jonathan L. Kravetz and William T. Whelan, Mr. Wiesen’s fellow Co-chairs of Mintz Levin’s Life Sciences Practice, were also recognized by Best Lawyers as leaders in Biotechnology Law for 2013.

Mintz Levin has served as one of the leading law firms to the life sciences industry since the industry’s birth in the 1970s. Today, the firm advises hundreds of businesses and other organizations in all sectors of the industry’s ecosystem — from start-ups looking for their first funding to public companies with products on the market, as well as venture capital firms, investment banks, and research and academic institutions. Mintz Levin attorneys provide experienced counsel to clients globally in a broad range of matters, including corporate finance and securities, mergers and acquisitions, licensing and collaborations, intellectual property, litigation, regulatory, employment and benefits, bankruptcy and commercial lending, immigration, and real estate. Mintz Levin is a full-service law firm comprised of 450 attorneys with eight offices (Boston, New York, San Diego, San Francisco, Washington, Stamford, Los Angeles, and London) and an affiliate relationship in Israel.

Posted in: Press Releases
Actions: E-mail | Permalink |